The Oncotype DX takes a look at maybe a genomic to take a look at that analyzes the activity of a bunch of genes that may have an effect on however cancer is probably going to behave and answer treatment. The Oncotype DX is employed in 2 ways:
- to help doctors understand a woman’s risk of early-stage, estrogen-receptor-positive carcinoma coming (recurrence), further as however seemingly she is to learn from therapy when carcinoma surgery
- to help doctors understand a woman’s risk of DCIS (ductal cancer in situ) coming (recurrence) and/or the chance of a replacement invasive cancer developing within the same breast, further as however seemingly she is to learn from radiotherapy when DCIS surgery
Of all the carcinoma genomic tests, the Oncotype DX takes a look at has the strongest analysis behind it.